Is selective therapy of recurrent nephrolithiasis possible?

Area of Science:

• Nephrology
• Urology
• Metabolic Disorders

Background:

• Recurrent nephrolithiasis poses a significant health challenge.
• Identifying and correcting underlying physicochemical and physiological derangements is crucial for effective management.
• Previous treatment approaches often lacked specificity for diverse etiologies.

Purpose of the Study:

• To evaluate the efficacy of tailored treatment programs for common causes of nephrolithiasis.
• To assess the impact of these selective therapies on stone recurrence and formation rates.
• To provide evidence supporting a personalized approach to nephrolithiasis management.

Main Methods:

• 128 patients with recurrent nephrolithiasis were enrolled.
• Seven distinct treatment groups were established based on specific underlying causes (e.g., absorptive hypercalciuria, renal hypercalciuria, hyperuricosuria).
• Therapies included sodium cellulose phosphate, thiazide diuretics, orthophosphate, allopurinol, dietary modifications, and fluid intake adjustments.
• Stone formation rates were compared during treatment (1.70–3.37 years) versus a pretreatment period (3 years).

Main Results:

• All seven treatment programs demonstrated a significant reduction in kidney stone formation.
• Remission rates ranged from 70% to 91%, with reduced stone formation observed in 88% to 100% of patients.
• Stone formation declined significantly from 1.90–2.28 stones/year to 0.09–0.55 stones/year.
• Actual stone formation during treatment was less than 26% of the predicted number based on pretreatment frequency.

Conclusions:

• Selective, cause-specific treatment programs are highly effective in managing recurrent nephrolithiasis.
• Personalized therapeutic strategies lead to substantial reductions in stone recurrence and high remission rates.
• The findings support a targeted approach to nephrolithiasis therapy based on individual patient derangements.